COOPER COMPANIES Report 10.3% Revenue Increase for Q3 FY2023

September 2, 2023

☀️Earnings Overview

COOPER ($NYSE:COO): Nonetheless, net income decreased 13.3% and stood at USD 85.3 million.


GoodWhale’s analysis of COOPER COMPANIES‘ fundamentals has been presented below. According to their Star Chart, COOPER COMPANIES is classified as ‘rhino’ – a type of company that has achieved moderate revenue or earnings growth. The company is particularly strong in terms of dividend and profitability, and medium in terms of asset and growth. They also have a very good health score of 8/10 considering their cashflows and debt, which makes them safe enough to ride out any crisis without the risk of bankruptcy. These characteristics make COOPER COMPANIES an attractive investment option for certain types of investors. For example, investors looking for a steady dividend yield will certainly be interested in this company. Investors who value strong profitability and asset stability will also find it attractive. And those who are looking for a safe haven during times of crisis will be reassured by the company’s high health score. In short, COOPER COMPANIES is an ideal investment option for those who value reliability and stability in their investments. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Cooper Companies. More…

    Total Revenues Net Income Net Margin
    3.51k 275.3 8.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Cooper Companies. More…

    Operations Investing Financing
    685.4 -1.83k 1.19k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Cooper Companies. More…

    Total Assets Total Liabilities Book Value Per Share
    11.7k 4.17k 149.02
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Cooper Companies are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    12.9% 11.8% 13.7%
    FCF Margin ROE ROA
    11.0% 4.1% 2.6%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items

  • Peers

    The Cooper Companies Inc and its competitors, Sonova Holding AG, Pfizer Inc, and Teleflex Inc, compete in the global medical device market. Sonova Holding AG is a leading manufacturer of hearing aids and other auditory products. Pfizer Inc is a leading manufacturer of pharmaceuticals, vaccines, and other health care products. Teleflex Inc is a leading manufacturer of medical devices and other health care products.

    – Sonova Holding AG ($LTS:0QPY)

    Sonova Holding AG is a global leader in providing hearing care solutions. The company has a market capitalization of 15.4 billion as of 2022 and a return on equity of 21.26%. Sonova’s products are sold in over 100 countries and the company has a strong presence in Europe, North America, and Asia Pacific. The company’s products include hearing aids, cochlear implants, and wireless communication solutions.

    – Pfizer Inc ($NYSE:PFE)

    Pfizer Inc is a multinational pharmaceutical corporation. It is one of the world’s largest pharmaceutical companies. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhard. The company has its headquarters in New York City.

    Pfizer’s market cap is $270.73 billion as of 2022. Its return on equity is 27.98%. The company manufactures and sells a broad range of pharmaceutical products, including prescription and over-the-counter drugs. The company’s products are sold in more than 150 countries.

    – Teleflex Inc ($NYSE:TFX)

    Teleflex Inc is a medical device company that provides products and services for a variety of medical conditions. The company has a market cap of 10.2B as of 2022 and a Return on Equity of 8.5%. Teleflex Inc’s products and services include catheters, respiratory devices, and surgical instruments. The company serves patients, families, and healthcare professionals worldwide.


    COOPER COMPANIES reported a 10.3% increase in total revenue for the third quarter of FY2023, ending July 31 2023, bringing the total to USD 930.2 million. Despite the positive revenue growth, net income was down 13.3% to USD 85.3 million. Investors should monitor the company’s progress in turning profits and focus on the root causes for the decline in profits to determine if this is an anomaly or an ongoing trend.

    Recent Posts

    Leave a Comment